SCHEMBL20732983

SCHEMBL20732983

Cn1cc(-c2ccc(-c3ccc4nccc(C#N)c4c3)cc2)cn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACVR1 Q04771 1/20 0.55
▸ LRRK2 Q5S007 2/20 0.54
▸ CCNC P24863 4/20 0.48
▸ CDK8 P49336 4/20 0.48
▸ ALK Q9UM73 1/20 0.47
▸ EGFR P00533 2/20 0.47
▸ ERBB2 P04626 2/20 0.47
▸ ERBB4 Q15303 2/20 0.47
▸ TGFBR1 P36897 1/20 0.46
▸ CSNK1A1 P48729 1/20 0.44
▸ CSNK1D P48730 1/20 0.44
▸ CSNK1G2 P78368 1/20 0.44
▸ PIK3CA P42336 3/20 0.44
▸ PIK3CD O00329 2/20 0.44
▸ PIK3CB P42338 2/20 0.44
▸ PIK3CG P48736 2/20 0.44
▸ MTOR P42345 1/20 0.44
▸ AXL P30530 1/20 0.43
▸ CREBBP Q92793 2/20 0.43
▸ PDE10A Q9Y233 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20732984 0.80 ACVR1 (0.59) ACVR1CCNCCDK8ALKEGFR
SCHEMBL20732940 0.77 TGFBR1 (0.39) ACVR1LRRK2CCNCCDK8TGFBR1
SCHEMBL20732986 0.76 ACVR1 (0.57) ACVR1LRRK2CCNCCDK8ALK
SCHEMBL20732859 0.76 CYP1A2 (0.54) ACVR1LRRK2TGFBR1
SCHEMBL22119753 0.74 ACVR1 (0.55) ACVR1LRRK2CCNCCDK8ALK
SCHEMBL18115936 0.74 CCNC (0.47) ACVR1LRRK2CCNCCDK8ALK
SCHEMBL30668661 0.74 CCNC (0.47) ACVR1LRRK2CCNCCDK8ALK
SCHEMBL20733053 0.73 MAPKAPK2 (0.56) ACVR1TGFBR1
SCHEMBL2662178 0.72 LRRK2 (0.51) LRRK2CCNCCDK8PIK3CAPIK3CD
SCHEMBL28509305 0.72 ACVR1 (0.49) ACVR1CCNCCDK8ALKEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3666770-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS Joint Stock Company "Biocad" (RU) 2020-06-17 — — EP disclosed
WO-2019031990-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS ЗАКРЫТОЕ АКЦИОНЕРНОЕ ОБЩЕСТВО "БИОКАД" 2019-02-14 — — WO disclosed
Send feedback